Literature DB >> 3036220

Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV.

K Nicolay, B de Kruijff.   

Abstract

The inhibition of respiratory chain activities in rat liver, rat heart and bovine heart mitochondria by the anthracycline antibiotic adriamycin was measured in order to determine the adriamycin-sensitive sites. It appeared that complex III and IV are efficiently affected such that their activities were reduced to 50% of control values at 175 +/- 25 microM adriamycin. Complex I displayed a minor sensitivity to the drug. Of the complex-I-related activities tested, only duroquinone oxidation appeared sensitive (50% inhibition at approx. 450 microM adriamycin). Electron-transfer activities catalyzed by complex II remained essentially unaltered up to high drug concentrations. Of the activities measured for this complex, only duroquinone oxidation was significantly affected. However, the adriamycin concentration required to reduce this activity to 50% exceeded 1 mM. Mitochondria isolated from rat liver, rat heart and bovine heart behaved essentially identical in their response to adriamycin. These data support the conclusion that, in these three mitochondrial systems, the major drug-sensitive sites lie in complex III and IV. Cytochrome c oxidase and succinate oxidase activity in whole mitochondria exhibited a similar sensitivity towards adriamycin, as inner membrane ghosts, suggesting that the drug has direct access to its inner membrane target sites irrespective of the presence of the outer membrane. By measuring NADH and succinate oxidase activities in the presence of exogenously added cytochrome c, it appeared that adriamycin was less inhibitory under these conditions. This suggests that adriamycin competes with cytochrome c for binding to the same site on the inner membrane, presumably cardiolipin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036220     DOI: 10.1016/0005-2728(87)90236-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.

Authors:  U Beyer; B Rothern-Rutishauser; C Unger; H Wunderli-Allenspach; F Kratz
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  An improved method for separating cardiolipin by HPLC.

Authors:  Gwendolyn Barceló-Coblijn; Eric J Murphy
Journal:  Lipids       Date:  2008-07-18       Impact factor: 1.880

3.  Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment.

Authors:  Y Zhao; S Miriyala; L Miao; M Mitov; D Schnell; S K Dhar; J Cai; J B Klein; R Sultana; D A Butterfield; M Vore; I Batinic-Haberle; S Bondada; D K St Clair
Journal:  Free Radic Biol Med       Date:  2014-03-12       Impact factor: 7.376

Review 4.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

5.  Simple discrimination of sub-cycling cells by propidium iodide flow cytometric assay in Jurkat cell samples with extensive DNA fragmentation.

Authors:  Ramona Madalina Babes; Ioana Teodora Tofolean; Roxana Gabriela Sandu; Oana Elena Baran; Vlad Cosoreanu; Maria Teodora Ilie; Alexandru Ionut Duta; Maria Catalina Ceausescu; Paul Mihai Ciucur; Simona Costache; Constanta Ganea; Irina Baran
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

Review 6.  Functional binding of cardiolipin to cytochrome c oxidase.

Authors:  N C Robinson
Journal:  J Bioenerg Biomembr       Date:  1993-04       Impact factor: 2.945

7.  Adriamycin induced myocardial failure in rats: protective role of Centella asiatica.

Authors:  A Gnanapragasam; S Yogeeta; R Subhashini; K K Ebenezar; V Sathish; T Devaki
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

8.  Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity.

Authors:  Salim Khiati; Ilaria Dalla Rosa; Carole Sourbier; Xuefei Ma; V Ashutosh Rao; Leonard M Neckers; Hongliang Zhang; Yves Pommier
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

Review 9.  Regulation of autophagy by mitochondrial phospholipids in health and diseases.

Authors:  Paul Hsu; Yuguang Shi
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-05       Impact factor: 4.698

10.  Binding of adriamycin to liposomes as a probe for membrane lateral organization.

Authors:  T Söderlund; A Jutila; P K Kinnunen
Journal:  Biophys J       Date:  1999-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.